HYDERABAD: Dr Reddy's Laboratories reported 8 percent annual growth in its consolidated net profit for Q4. Dr Reddy's Laboratories reported a net profit of Rs 519 crore over sales of Rs 3,870 crore in the quarter ended March 31, 2015. The company had reported a net profit of Rs 482 crore on sales of Rs 3,480 crore in the corresponding quarter of last fiscal.
For the year 2014-15 the company has seen 12 percent growth in revenues at Rs 14,819 crore with 3 percent growth in net profit at Rs 2,218 crore.
Dr Reddy's net profit in the Q4 was impacted by forex losses of Rs 84.3 crore high research & development (R&D) expenses which came in at Rs 514 crore against Rs 398 crore year-on-year. Operating profit (EBITDA) of the company came in at Rs 810 crore against Rs 781 crore year-on-year and its operating margin, a major of profitability declined 80 basis points annually to 21 percent.
The company's co-chairman and chief executive officer Mr GV Prasad said, "Overall, our results demonstrate our commitment to execute on our strategy, across businesses, as we constantly strengthen our focus on patients and providing them access."
The company has declared a dividend of Rs 20 per share.
